Fludarabine is an effective treatment for chronic lymphocytic leukemia (CLL) that has not responded to other types of chemotherapy, such as chlorambucil or cyclophosphamide. Studies are ongoing to find out the safety and effectiveness of fludarabine in people who have not received other types of chemotherapy or who are responding to other types of chemotherapy.
Side effects are common with fludarabine and can include:
The Health Encyclopedia contains general health information. Not all treatments or services described are covered benefits for Kaiser Permanente members or offered as services by Kaiser Permanente. For a list of covered benefits, please refer to your Evidence of Coverage or Summary Plan Description. For recommended treatments, please consult with your health care provider.